Skip to search boxSkip to navigationSkip to main content

Impact of type 2 myocardial infarction (MI) on hospital-level MI outcomes: Implications for quality and public reporting

  • Sameer Arora(corresponding author)
    ,
  • Paula D. Strassle
    ,
  • Arman Qamar
    ,
  • Evan N. Wheeler
    ,
  • Alexandra L. Levine
    ,
  • Jacob A. Misenheimer
*Corresponding author for this work
  • University of North Carolina at Chapel Hill
    ,
  • Brigham and Women’s Hospital
    ,
  • Campbell University
    ,
  • ,
  • Piedmont Heart Institute
Scholary Output:
Contribution to journal
Article
Peer-review

Abstract

Background--The International Classification of Diseases (ICD) coding system does not recognize type 2 myocardial infarction (MI) as a separate entity; therefore, patients with type 2 MI continue to be categorized under the general umbrella of non-ST-segment- elevation myocardial infarction (NSTEMI). We aim to evaluate the impact of type 2 MI on hospital-level NSTEMI metrics and discuss the implications for quality and public reporting. Methods and Results--We conducted a single-center retrospective analysis of 1318 patients discharged with a diagnosis of NSTEMI between July 2013 and October 2014. The Third Universal Definition was used to define type 1 and type 2 MI. Weighted Kaplan-Meier curves were used to analyze risk of mortality and readmission. Overall, 1039 patients met NSTEMI criteria per the Third Universal Definition; of those, 264 (25.4%) had type 2 MI. Patients with type 2 MI were older, were more likely to have chronic kidney disease, and had lower peak troponin levels. Compared with type 1 MI patients, those with type 2 MI had higher inpatient mortality (17.4% versus 4.7%, P < 0.0001) and were more likely to die from noncardiovascular causes (71.7% versus 25.0%, P < 0.0001). Despite weighting for patient characteristics and discharge medications, patients with type 2 MI had higher mortality at both 30 days (risk ratio: 3.63; 95% confidence interval, 1.67-7.88) and 1 year (risk ratio: 1.98; 95% confidence interval, 1.44-2.73) after discharge. Type 2 MI was also associated with a lower 30-day cardiovascular-related readmission (risk ratio: 0.49; 95% confidence interval, 0.12-2.06). Conclusions--NSTEMI metrics are significantly affected by type 2 MI patients. Type 2 MI patients have distinct etiologies, are managed differently, and have higher mortality compared with patients with type 1 MI. Moving forward, it may be appropriate to exclude type 2 MI data from NSTEMI quality metrics.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Article number

e008661

Journal (Volume, Issue Number)

Journal of the American Heart Association (Volume 7, Issue 7)

Publication milestones

  • Published - 04/01/2018

Publication status

Published - 04/01/2018

ISSN

2047-9980

Publication IDs

  • Scopus: 85044853471
  • PubMed: 29581221

Publication metrics

Metrics

Scopus
citations
Fractional count
1
Fractional count
0.11
Fractional count
8
Fractional count
0.89
Fractional count
1
Fractional count
1
SciVal
FWCI
2.46
SciVal
Author count
9
SciVal
citations
22
SciVal
Paper percentile
93
SciVal
Top percentile
10

PlumX, opens in new tab

Captures
33
Citation count
48

Funding Details

FunderFunding number
NHLBI
T32HL007604